Verismo Therapeutics
3675 Market St Suite 200 Philadelphia, Pennsylvania 19104, UShttps://verismotherapeutics.com/Therapeutics
A clinical-stage CAR T cell therapy company pioneering a novel multi-chain KIR-CAR platform technology to develop targeted cell therapies for cancer. Focused on advancing clinical-stage programs, including SynKIR™-110 for advanced solid tumors and SynKIR™-310 for B cell non-Hodgkin lymphoma.
Leadership & Board
- Current Number of Employees
- 32
- Current LinkedIn Followers
- 7,437
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $28M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $28M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Employee Trend
Verismo Therapeutics had 32 employees as of October 12, 2026. The number of employees increased by 1 (3.23%) week-over-week.
32Latest Employee Count
1(3.23%)Week-Over-Week Change
Social Trend
Verismo Therapeutics had 7,437 followers as of October 12, 2026. The number of followers increased by 4 (0.05%) week-over-week.
7,437Latest Followers Count
4(0.05%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 15, 2026 | Investment | $28.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| HLB Innovation | Investment |
Similar Companies
A snapshot of private companies similar to Verismo Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
